Humira for Crohns
Links shared publicly online about this topic
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints In Phase III Ulcerative Colitis Study
medicalnewstoday.com — “Abbott's (NYSE: ABT) HUMIRA® (adalimumab) met its primary endpoint of clinical remission in a Phase III study of adult patients with moderate to severe ulcerative colitis. Results were presen” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2011 at 7:05 am By:
Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints In Phase III Ulcerative Colitis Study http://mnt.to/3VGk #crohns #ibd
Sign In to Crohn's Disease Support Network - CDSN - Crohn's Disease Support Network - CDSN
crohnsdiseasesn.com — “Spreading Crohn's Disease awareness because relating to each other, and knowing you are not alone is often the best medicine!” View full resource at crohnsdiseasesn.com
Most Recently Shared on January 23, 2010 at 2:19 pm By:
@salcdl stopping the Humira - I commented on my experience of it here: http://bit.ly/5Ebktx in the Crohn's and Medication group :) #CDSN
Surveyed Gastroenterologists Will Treat Fewer Crohn's Disease Patients With Remicade
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed gastroenterologists estimate that (assuming no new data on” View full resource at medicalnewstoday.com
Most Recently Shared on April 8, 2010 at 12:06 pm By:
Surveyed Gastroenterologists Will Treat Fewer Crohn's Disease Patients With Remicade http://mnt.to/3zX4 #crohns #ibd
Prometheus And Tarrot Laboratories Collaborate To Identify Markers Associated With Response To Anti-TNF Therapies In Crohn's Disease
medicalnewstoday.com — “Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, announced the execution of an exclusive re” View full resource at medicalnewstoday.com
Most Recently Shared on September 18, 2010 at 12:24 pm By:
Drugs and Devices OW OW Health
Prometheus And Tarrot Laboratories Collaborate To Identify Markers Associated With Response To Anti-TNF ... http://mnt.to/f/3K2g #MedDevice
Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
fda.gov — “Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)” View full resource at fda.gov
Most Recently Shared on August 5, 2009 at 4:45 pm By:
FDA warns of possible connection between drugs for inflammatory disorders and cancer in kids: http://bit.ly/BvQDV
Crohn's Disease Support Network - CDSN
crohnsdiseasesn.com — “Spreading Crohn's Disease awareness because relating to each other, and knowing you are not alone is often the best medicine!” View full resource at crohnsdiseasesn.com
Most Recently Shared on July 22, 2011 at 7:35 am By:
Just added a new discussion on #CDSN Multiple Lawsuits Claim Humira caused Permanent Nerve Damage. http://ning.it/pbMoDx
Crohn's Disease Support Network - CDSN
crohnsdiseasesn.com — “Spreading Crohn's Disease awareness because relating to each other, and knowing you are not alone is often the best medicine!” View full resource at crohnsdiseasesn.com
Most Recently Shared on May 7, 2011 at 11:02 pm By:
Just added a new discussion on#CDSN "Humira levels detected in cord blood and infants exposed in utero" http://ning.it/leyADB
Comments of using Remicade (study 4018339) - eHealthMe.com
ehealthme.com — “Couldn't walk after second Remicade infusion for Crohn's. Was switched to Humira with same results. Am now bedridden and can no longer work outside the home. Mayo Clinic diagnosed it as drug-induced lupus but blood markers are changing while symptoms are not.” View full resource at ehealthme.com
Most Recently Shared on December 12, 2011 at 10:11 am By:
Couldn't walk after second Remicade infusion for Crohn's. Was switched to Humira with same results. Am now be http://t.co/tbkKPdxZ
Summary Box: Abbott beats earnings estimates
health.yahoo.net — “WITHDRAWALS AND RECALLS: Drug and medical device maker Abbott Laboratories reported a 40 percent drop in net income for the third quarter, due in part to a recall of baby formula and the withdrawal of its diet drug Meridia.” View full resource at health.yahoo.net
Most Recently Shared on October 20, 2010 at 5:09 pm By:
Jane Anderson Healthy Eating Advisor
Summary Box: Abbott beats earnings estimates http://bit.ly/cDvbIJ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Crohn's / IBD
The latest crohn's disease and IBD news published daily. Articles from research centers, universities and prestigious journals.
-
Jason Leitman
I am 30 Founder of The Crohn's Disease Support Network - CDSN. I also have a personal blog http://jasonandcrohnsdisease.blogspot.com/ Skype: JasonM31480
-
MNT Crohn's / IBD
The latest crohn's disease and IBD news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
